Edwards Lifesciences Corp
NYSE:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
NYSE:EW
Watchlist
Price: 83.1 USD -0.88%
Market Cap: 48.2B USD
Section:
 

Relative Value

The Relative Value of one EW stock under the Base Case scenario is 70.13 USD. Compared to the current market price of 83.1 USD, Edwards Lifesciences Corp is Overvalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EW Relative Value
Base Case
70.13 USD
Overvaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.2
P/S
P/S
Price to Sales
8.2
vs History
73
vs Industry
17
Median 3Y
8.4
Median 5Y
9.4
Industry
2.4
Forward
7.8
More Details
35.3
P/E
P/E
Price to Earnings
35.3
vs History
50
vs Industry
40
Median 3Y
32.4
Median 5Y
35.9
Industry
22.9
Forward
31.3
More Details
47.5
P/OCF
P/OCF
Price to OCF
47.5
vs History
52
vs Industry
3
Median 3Y
49.4
Median 5Y
48.3
Industry
14.7
More Details
60.4
P/FCFE
P/FCFE
Price to FCFE
60.4
vs History
57
vs Industry
2
Median 3Y
73.1
Median 5Y
67.6
Industry
21.4
More Details
4.7
P/B
P/B
Price to Book Value
4.7
vs History
76
vs Industry
19
Median 3Y
5.8
Median 5Y
7.8
Industry
2.3
More Details
7.7
EV/S
EV/S
Enterprise Value to Sales
7.7
vs History
71
vs Industry
17
Median 3Y
7.8
Median 5Y
9.2
Industry
2.6
Forward
7.2
More Details
9.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.8
vs History
69
vs Industry
23
Median 3Y
10
Median 5Y
11.6
Industry
5.3
More Details
25.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.2
vs History
65
vs Industry
13
Median 3Y
25
Median 5Y
27
Industry
12.3
Forward
24
More Details
27.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.6
vs History
63
vs Industry
17
Median 3Y
27.3
Median 5Y
29.5
Industry
17.2
Forward
26.3
More Details
44.3
EV/OCF
EV/OCF
Enterprise Value to OCF
44.3
vs History
55
vs Industry
3
Median 3Y
46.5
Median 5Y
45.1
Industry
15
More Details
56.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
56.3
vs History
58
vs Industry
3
Median 3Y
68.3
Median 5Y
65.4
Industry
19
More Details
4.9
EV/IC
EV/IC
Enterprise Value to IC
4.9
vs History
76
vs Industry
18
Median 3Y
5.5
Median 5Y
7.1
Industry
1.9
More Details

Multiples Across Competitors

EW Competitors Multiples
Edwards Lifesciences Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Edwards Lifesciences Corp
NYSE:EW
48.3B USD 8.2 35.3 25.2 27.6
US
Abbott Laboratories
NYSE:ABT
216.3B USD 4.9 15.5 19.7 27.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
196B USD 20.4 71.4 54.6 66.6
US
Boston Scientific Corp
NYSE:BSX
138.9B USD 7.2 49.8 29.1 39.6
US
Stryker Corp
NYSE:SYK
137.4B USD 5.6 46.7 22.8 27.6
IE
Medtronic PLC
NYSE:MDT
126.6B USD 3.6 26.6 14.9 21.6
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.2 24.3 13.7 19.3
US
Becton Dickinson and Co
NYSE:BDX
59.2B USD 2.7 35.3 12.9 22
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.8B USD 13.6 55.3 39.7 44
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.9B USD 1.9 17.5 13 15.8
US
Resmed Inc
NYSE:RMD
37.9B USD 7.2 26.3 18.9 21

See Also

Summary
EW intrinsic value, competitors valuation, and company profile.
DCF Valuation
EW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EW stock valuation using valuation multiples.
Wall Street Estimates
EW price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.